Evidence map›Paper›PMID 38366961›Full record

ArticleEpilepsia open2024

Long-term outcomes after new onset seizure in children living with HIV: A cohort study.

Gretchen L Birbeck, Musaku Mwenechanya, Ifunanya Ume-Ezeoke, Manoj Mathews, Christopher M Bositis, Lisa Kalungwana, David Bearden, Melissa Elafros, Harris A Gelbard, William H Theodore and 7 more

Open access · goldAbstract read
In one paragraph

Article in Epilepsia open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

Gretchen L BirbeckDepartment of Neurology, University of Rochester, Rochester, New York, USA.ORCID https://orcid.org/0000-0002-0735-3461
Musaku MwenechanyaUniversity Teaching Hospitals Children's Hospital, Lusaka, Zambia.
Ifunanya Ume-EzeokeDepartment of Neurology, University of Rochester, Rochester, New York, USA.
Manoj MathewsUniversity Teaching Hospitals Children's Hospital, Lusaka, Zambia.
Christopher M BositisDepartment of Family and Community Medicine, University of California San Francisco, San Francisco, California, USA.
Lisa KalungwanaDepartment of Psychology, University of Zambia, Lusaka, Zambia.
David BeardenDepartment of Neurology, University of Rochester, Rochester, New York, USA.
Melissa ElafrosDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Harris A GelbardDepartment of Neurology, University of Rochester, Rochester, New York, USA.
William H TheodoreClinical Epilepsy Section, US National Institute of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-4669-5747
Igor J KoralnikDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Jason F OkuliczDepartment of Medicine, San Antonio Military Medical Center, San Antonio, Texas, USA.
Brent A JohnsonDepartment of Biostatistics, University of Rochester, Rochester, New York, USA.
Namwiya MusondaUniversity Teaching Hospitals Neurology Research Office, Lusaka, Zambia.
Omar K SiddiqiUniversity Teaching Hospitals Children's Hospital, Lusaka, Zambia.
Michael J PotchenDepartment of Imaging Sciences, University of Rochester, Rochester, New York, USA.
Izukanji SikazweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
University Teaching Hospital · ZMUniversity of Rochester · USUniversity of Zambia · ZMBeth Israel Deaconess Medical Center · USBrooke Army Medical Center · USCentre for Infectious Disease Research in Zambia · ZMNorthwestern University · USUniversity of California, San Francisco · USUniversity of Michigan · US

Funding

Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology)R35NS122265 · NINDS · UNIVERSITY OF ROCHESTER · PI GRETCHEN L. BIRBECK · 2021 to 2026
$3.1M
Cohort of HIV-Associated Seizures and Epilepsy in Zambia (CHASE): Scale up and expansion informed by R21 FindingsR01NS094037 · NINDS · UNIVERSITY OF ROCHESTER · PI BIRBECK, GRETCHEN L., SIKAZWE, IZUKANJI · 2015 to 2019
$3.0M
Longitudinal Cognitive Outcomes in Children and Adolescents with HIV in ZambiaK23NS117310 · NINDS · UNIVERSITY OF ROCHESTER · PI BEARDEN, DAVID ROSS · 2020 to 2024
$1.0M
NINDS NIH HHS K23 NS117310NINDS NIH HHS K23NS117310NINDS NIH HHS R01 NS094037NINDS NIH HHS R01NS094037NINDS NIH HHS R35 NS122265NINDS NIH HHS R35NS122265
6 · The paper itself

Abstract

objectiveTo determine the long-term outcomes, including mortality and recurrent seizures, among children living with HIV (CLWH) who present with new onset seizure.

methodsZambian CLWH and new onset seizure were enrolled prospectively to determine the risk of and risk factors for recurrent seizures. Demographic data, clinical profiles, index seizure etiology, and 30-day mortality outcomes were previously reported. After discharge, children were followed quarterly to identify recurrent seizures and death. Given the high risk of early death, risk factors for recurrent seizure were evaluated using a model that adjusted for mortality.

resultsAmong 73 children enrolled, 28 died (38%), 22 within 30-days of the index seizure. Median follow-up was 533 days (IQR 18-957) with 5% (4/73) lost to follow-up. Seizure recurrence was 19% among the entire cohort. Among children surviving at least 30-days after the index seizure, 27% had a recurrent seizure. Median time from index seizure to recurrent seizure was 161 days (IQR 86-269). Central nervous system opportunistic infection (CNS OI), as the cause for the index seizure was protective against recurrent seizures and higher functional status was a risk factor for seizure recurrence. SIGNIFICANCE: Among CLWH presenting with new onset seizure, mortality risks remain elevated beyond the acute illness period. Recurrent seizures are common and are more likely in children with higher level of functioning even after adjusting for the outcome of death. Newer antiseizure medications appropriate for co-usage with antiretroviral therapies are needed for the care of these children. CNS OI may represent a potentially reversible provocation for the index seizure, while seizures in high functioning CLWH without a CNS OI may be the result of a prior brain injury or susceptibility to seizures unrelated to HIV and thus represent an ongoing predisposition to seizures. PLAIN LANGUAGE SUMMARY: This study followed CLWH who experienced a new onset seizure to find out how many go on to have more seizures and identify any patient characteristics associated with having more seizures. The study found that mortality rates continue to be high beyond the acute clinical presentation with new onset seizure. Children with a CNS OI causing the new onset seizure had a lower risk of later seizures, possibly because the trigger for the seizure can be treated. In contrast, high functioning children without a CNS OI were at higher risk of future seizures.

Indexed as

Epilepsy, GeneralizedHIV InfectionsAnticonvulsantsBrain Damage, ChronicChildCohort StudiesHumansSeizuresAnticonvulsantscentral nervous system opportunistic infectionepilepsyfunctional statusLansky scoreorphanseizure recurrence

Identifiers

PMID38366961
PMCPMC10984287
OpenAlexW4391913913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.